U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Facial myokymia

MedGen UID:
78741
Concept ID:
C0270871
Disease or Syndrome
Synonyms: Facial Myokymia; Facial Myokymias; Myokymia, Facial; Myokymias, Facial
SNOMED CT: Facial myokymia (1070000); Facial myokymia (muscle quivering) (1070000)
 
HPO: HP:0000317
Monarch Initiative: MONDO:0016373

Definition

Facial myokymia is a fine fibrillary activity of one or more muscles innervated by the facial nerve (the seventh cranial nerve). [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVFacial myokymia

Conditions with this feature

Spinocerebellar ataxia type 5
MedGen UID:
155705
Concept ID:
C0752123
Disease or Syndrome
For a general discussion of autosomal dominant spinocerebellar ataxia (SCA), see SCA1 (164400).
Spinocerebellar ataxia type 25
MedGen UID:
373347
Concept ID:
C1837518
Disease or Syndrome
Spinocerebellar ataxia-25 (SCA25) is an autosomal dominant neurologic disorder characterized by the onset of lower limb ataxia resulting in gait difficulties in the first few decades of life, although later onset has been reported. Affected individuals often have upper limb involvement, dysarthria, scoliosis, abnormal eye movements, and sensory neuropathy with decreased reflexes. Some patients have sensorineural hearing loss. Brain imaging shows cerebellar atrophy. There is incomplete penetrance and variable expressivity, even within families (Barbier et al., 2022). For a general discussion of autosomal dominant spinocerebellar ataxia, see SCA1 (164400).
Spinocerebellar ataxia type 14
MedGen UID:
343106
Concept ID:
C1854369
Disease or Syndrome
Spinocerebellar ataxia type 14 (SCA14) is characterized by slowly progressive cerebellar ataxia, dysarthria, and nystagmus. Axial myoclonus, cognitive impairment, tremor, and sensory loss may also be observed. Parkinsonian features including rigidity and tremor have been described in some families. Findings seen in other ataxia disorders (e.g., dysphagia, dysphonia) may also occur in SCA14. The average age of onset is in the 30s, with a range from childhood to the seventh decade. Life span is not shortened.
Spinocerebellar ataxia type 12
MedGen UID:
347653
Concept ID:
C1858501
Disease or Syndrome
Rare disease with manifestations of action tremor associated with relatively mild cerebellar ataxia. Associated pyramidal and extrapyramidal signs and dementia have been reported. Prevalence is unknown. Approximately 40 families have been reported. The pathogenesis seems to be related to a toxic effect at the RNA level as it is caused by a CAG expansion at the 5'' end of the PPP2R2B gene on chromosome 5q31-5q32.
Dyskinesia with orofacial involvement, autosomal dominant
MedGen UID:
1790407
Concept ID:
C5551343
Disease or Syndrome
ADCY5 dyskinesia is a hyperkinetic movement disorder (more prominent in the face and arms than the legs) characterized by infantile to late-adolescent onset of chorea, athetosis, dystonia, myoclonus, or a combination of these. To date, affected individuals have had overlapping (but not identical) manifestations with wide-ranging severity. The facial movements are typically periorbital and perioral. The dyskinesia is prone to episodic or paroxysmal exacerbation lasting minutes to hours, and may occur during sleep. Precipitating factors in some persons have included emotional stress, intercurrent illness, sneezing, or caffeine; in others, no precipitating factors have been identified. In some children, severe infantile axial hypotonia results in gross motor delays accompanied by chorea, sometimes with language delays. The overall tendency is for the abnormal movements to stabilize in early middle age, at which point they may improve in some individuals; less commonly, the abnormal movements are slowly progressive, increasing in severity and frequency.
Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects
MedGen UID:
1823972
Concept ID:
C5774199
Disease or Syndrome
Intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects (IDDMDS) is an autosomal recessive disorder characterized by global developmental delay apparent in infancy manifest as speech delay and late walking by a few years. Affected individuals have hypertonia or, more rarely, hypotonia; a notable common feature is facial myokymia with corresponding EMG findings. Additional features include distal skeletal defects such as joint contractures, hypo- or areflexia, and hernia (Marafi et al., 2022).

Professional guidelines

PubMed

Marin Collazo IV, Tobin WO
Neurologist 2018 Jan;23(1):1-6. doi: 10.1097/NRL.0000000000000163. PMID: 29266036
Habek M, Karni A, Balash Y, Gurevich T
Clin Neurol Neurosurg 2010 Sep;112(7):592-6. Epub 2010 Jul 8 doi: 10.1016/j.clineuro.2010.04.010. PMID: 20615606
Jabbari B, Scherokman B, Gunderson CH, Rosenberg ML, Miller J
Mov Disord 1989;4(3):202-12. doi: 10.1002/mds.870040302. PMID: 2779591

Recent clinical studies

Etiology

Ghosh R, Roy D, Dubey S, Das S, Benito-León J
Tremor Other Hyperkinet Mov (N Y) 2022;12:14. Epub 2022 May 4 doi: 10.5334/tohm.671. PMID: 35601204Free PMC Article
Camelo CG, Silva AMS, Moreno CAM, Matsui-Júnior C, Heise CO, Pedroso JL, Zanoteli E
Pract Neurol 2020 May;20(3):253-255. Epub 2020 Mar 17 doi: 10.1136/practneurol-2019-002462. PMID: 32184343
Marin Collazo IV, Tobin WO
Neurologist 2018 Jan;23(1):1-6. doi: 10.1097/NRL.0000000000000163. PMID: 29266036
Beckmann Y, Çiftçi Y, Incesu TK, Seçil Y, Akhan G
Acta Neurol Belg 2014 Dec;114(4):303-6. Epub 2014 Mar 7 doi: 10.1007/s13760-014-0284-0. PMID: 24604683
Raskind WH, Matsushita M, Peter B, Biberston J, Wolff J, Lipe H, Burbank R, Bird TD
Am J Med Genet B Neuropsychiatr Genet 2009 Jun 5;150B(4):570-4. doi: 10.1002/ajmg.b.30879. PMID: 18980218Free PMC Article

Diagnosis

Ghosh R, Roy D, Dubey S, Das S, Benito-León J
Tremor Other Hyperkinet Mov (N Y) 2022;12:14. Epub 2022 May 4 doi: 10.5334/tohm.671. PMID: 35601204Free PMC Article
Lefaucheur JP, Ben Daamer N, Sangla S, Le Guerinel C
Neurochirurgie 2018 May;64(2):82-86. Epub 2018 Apr 16 doi: 10.1016/j.neuchi.2017.12.003. PMID: 29673578
Tan NC, Chan LL, Tan EK
QJM 2002 Aug;95(8):493-500. doi: 10.1093/qjmed/95.8.493. PMID: 12145388
Riaz G, Campbell WW, Carr J, Ghatak N
Arch Neurol 1990 Apr;47(4):472-4. doi: 10.1001/archneur.1990.00530040130030. PMID: 2181981
Radü EW, Skorpil V, Kaeser HE
Eur Neurol 1975;13(6):499-512. doi: 10.1159/000114706. PMID: 1193097

Therapy

Kim JH, Jung HH, Chang JH, Chang JW, Park YG, Chang WS
World Neurosurg 2017 Nov;107:175-184. Epub 2017 Aug 5 doi: 10.1016/j.wneu.2017.07.139. PMID: 28826715
Habek M, Karni A, Balash Y, Gurevich T
Clin Neurol Neurosurg 2010 Sep;112(7):592-6. Epub 2010 Jul 8 doi: 10.1016/j.clineuro.2010.04.010. PMID: 20615606
Tan NC, Chan LL, Tan EK
QJM 2002 Aug;95(8):493-500. doi: 10.1093/qjmed/95.8.493. PMID: 12145388
Sedano MJ, Trejo JM, Macarrón JL, Polo JM, Berciano J, Calleja J
Eur Neurol 2000;43(3):137-40. doi: 10.1159/000008152. PMID: 10765052
Jabbari B, Scherokman B, Gunderson CH, Rosenberg ML, Miller J
Mov Disord 1989;4(3):202-12. doi: 10.1002/mds.870040302. PMID: 2779591

Prognosis

Raskind WH, Matsushita M, Peter B, Biberston J, Wolff J, Lipe H, Burbank R, Bird TD
Am J Med Genet B Neuropsychiatr Genet 2009 Jun 5;150B(4):570-4. doi: 10.1002/ajmg.b.30879. PMID: 18980218Free PMC Article
Blunt SB, Khalil NM, Perkin GD
Mov Disord 1997 Mar;12(2):235-8. doi: 10.1002/mds.870120215. PMID: 9087983
Boghen DR
Curr Opin Ophthalmol 1996 Dec;7(6):48-52. doi: 10.1097/00055735-199612000-00008. PMID: 10166553
Krauss JK, Wakhloo AK, Scheremet R, Seeger W
Neurosurgery 1993 Jun;32(6):1031-4. doi: 10.1227/00006123-199306000-00027. PMID: 8327079
Mateer JE, Gutmann L, McComas CF
Neurology 1983 Mar;33(3):374-6. doi: 10.1212/wnl.33.3.374. PMID: 6681885

Clinical prediction guides

Kim JH, Jung HH, Chang JH, Chang JW, Park YG, Chang WS
World Neurosurg 2017 Nov;107:175-184. Epub 2017 Aug 5 doi: 10.1016/j.wneu.2017.07.139. PMID: 28826715
Raskind WH, Matsushita M, Peter B, Biberston J, Wolff J, Lipe H, Burbank R, Bird TD
Am J Med Genet B Neuropsychiatr Genet 2009 Jun 5;150B(4):570-4. doi: 10.1002/ajmg.b.30879. PMID: 18980218Free PMC Article
Oge AE, Yayla V, Demir GA, Eraksoy M
Clin Neurophysiol 2005 Jul;116(7):1542-54. doi: 10.1016/j.clinph.2005.02.021. PMID: 15953558
Jacobs L, Kaba S, Pullicino P
Arch Neurol 1994 Nov;51(11):1115-9. doi: 10.1001/archneur.1994.00540230053012. PMID: 7980106
Bettoni L, Bortone E, Ghizzoni P, Lechi A
J Neurol Sci 1988 Mar;84(1):69-76. doi: 10.1016/0022-510x(88)90175-x. PMID: 3367153

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...